Kyra Doumlele, BA; Daniel Friedman, MD; Jeffrey Buchhalter, MD, PhD; et al.
free access
JAMA Neurol. 2017;74(6):645-649. doi:10.1001/jamaneurol.2016.6126
This case series examines whether cases of benign epilepsy with centrotemporal spikes are present in the North American SUDEP (Sudden Unexpected Death in Epilepsy) Registry.
Stefanie Schreiber, MD; Frank Schreiber, MSc; Samuel N. Lockhart, PhD; et al.
free access
JAMA Neurol. 2017;74(6):650-659. doi:10.1001/jamaneurol.2016.5349
This longitudinal cohort study examines patterns of neurodegeneration patterns in individuals with β-amyloid peptide–negative suspected non-Alzheimer disease pathophysiology compared with their β-amyloid peptide–positive counterparts.
Christian Lunetta, MD; Andrea Lizio, MS; Eleonora Maestri, BS; et al.
free access
JAMA Neurol. 2017;74(6):660-667. doi:10.1001/jamaneurol.2016.6179
This cohort study examines the prognostic significance of C-reactive protein in amyotrophic lateral sclerosis.
Neda Razaz, MPH, PhD; Kristina Tedroff, MD, PhD; Eduardo Villamor, MD, MPH, PhD; et al.
free access
JAMA Neurol. 2017;74(6):668-676. doi:10.1001/jamaneurol.2016.6130
This population-based study evaluates the incidence of childhood-onset epilepsy in mothers who were overweight or obese during early pregnancy.
Weihua Zhao, MD, PhD; David R. Beers, PhD; Kristopher G. Hooten, MD; et al.
free access
JAMA Neurol. 2017;74(6):677-685. doi:10.1001/jamaneurol.2017.0357
This study characterizes the transcriptomics of peripheral monocytes in patients with amyotrophic lateral sclerosis.
Ewen W. Sommerville, MSc; Yi Shiau Ng, MRCP; Charlotte L. Alston, BSc (Hons); et al.
free access
JAMA Neurol. 2017;74(6):686-694. doi:10.1001/jamaneurol.2016.4357
This case series study examines the myopathy, lactic acidosis, and sideroblastic anemia associated with YARS2-related mitochondrial disease.
Mary G. George, MD, MSPH; Xin Tong, MPH; Barbara A. Bowman, PhD
free access
has audio
JAMA Neurol. 2017;74(6):695-703. doi:10.1001/jamaneurol.2017.0020
This analysis of data from the National Inpatient Sample examines whether stroke hospitalization rates have continued to increase and identifies the prevalence of associated stroke risk factors among younger adults aged 18 to 54 years.
-
Podcast:
Prevalence of Cardiovascular Risk Factors and Strokes in Younger Adults (JAMA Neurology)
Ashutosh P. Jadhav, MD, PhD; Mehdi Bouslama, MD; Amin Aghaebrahim, MD; et al.
free access
JAMA Neurol. 2017;74(6):704-709. doi:10.1001/jamaneurol.2017.0192
This case-control study compares clinical and angiographic outcomes between monitored anesthesia care and general anesthesia in patients presenting with vertebrobasilar occlusion strokes.
Elizabeth I. Pierpont, PhD; Julie B. Eisengart, PhD; Ryan Shanley, MS; et al.
free access
JAMA Neurol. 2017;74(6):710-717. doi:10.1001/jamaneurol.2017.0013
This cohort study characterizes neurocognitive outcomes of boys with childhood cerebral adrenoleukodystrophy and early-stage cerebral disease who were treated with an allogeneic hematopoietic stem cell transplant and identifies disease- and treatment-related factors associated with long-term functioning.
Prashanthi Vemuri, PhD; David S. Knopman, MD; Timothy G. Lesnick, MS; et al.
free access
JAMA Neurol. 2017;74(6):718-726. doi:10.1001/jamaneurol.2017.0244
This cohort study explores whether amyloid protective factors and Alzheimer disease–pattern neurodegeneration protective factors differ in elderly individuals with Alzheimer disease and identifies midlife risk factors associated with amyloid deposition.
Jian Hao, PhD; Dorothy I. Kelly, MA; Jianzhong Su, PhD; et al.
free access
JAMA Neurol. 2017;74(6):727-732. doi:10.1001/jamaneurol.2017.0298
This worldwide patient registry study examines the most common features of glucose transporter type 1 deficiency.